Technology | Robotic Systems | October 28, 2015

Stereotaxis Introduces Respiratory Compensation for Remote Magnetic Navigation Procedures

Ablation system now uses algorithm to correct for respiratory motion of the heart during cardiac ablation procedures

Stereotaxis, Niobe remote magnetic navigation system, respiratory compensation, cardiac ablation

October 28, 2015 — Stereotaxis Inc. announced the worldwide launch of Respiratory Compensation, a new software feature of the company’s Niobe remote magnetic navigation system.

Respiratory Compensation is designed to further enhance the quality and accuracy of Ablation History and the automation features of the Niobe system by compensating for respiratory motion during an ablation procedure.     

“With the stable focal contact Niobe provides, the latest iteration of Ablation History and Respiratory Compensation creates a more precise representation of where lesion sets are actually being created. I am confident this further improves my ability to create contiguous lesions,” said Peter Weiss, M.D. of Intermountain Medical Center in Salt Lake City, an early adopter of the software upgrade.

Respiratory motion of the heart during cardiac ablation procedures can affect the quality and accuracy of catheter localization within mapping technologies and the automation capabilities of the Niobe system. Respiratory Compensation corrects this distortion by automatically monitoring the movements of a reference catheter over the respiratory cycle and applying an algorithm, involving both the ablation and reference catheters, to filter out respiratory motion. Calculating the correct position of the ablation catheter over the respiratory cycle provides the physician with clearer ablation information and improves the automatic movement of the ablation catheter to targeted positions.

In 2014, the company introduced the Ablation History software feature to the Niobe system, which provides a real-time, visual display of the catheter’s power output and duration, giving the physician greater visibility of potential lesion gaps, one of the common failure points to achieving favorable ablation outcomes.

For more information: www.stereotaxis.com


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now